HeartBeam Inc (BEAT) USD0.0001

Sell:$2.08Buy:$2.44$0.13 (5.83%)

Prices delayed by at least 15 minutes
Sell:$2.08
Buy:$2.44
Change:$0.13 (5.83%)
Prices delayed by at least 15 minutes
Sell:$2.08
Buy:$2.44
Change:$0.13 (5.83%)
Prices delayed by at least 15 minutes

Company Information

About this company

HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.

Key people

Richard M. Ferrari
Executive Chairman of the Board
Branislav Vajdic
President, Founder, Director
Robert P. Eno
Chief Executive Officer
Timothy Cruickshank
Chief Financial Officer
Kenneth Persen
Chief Technical Officer
George A. De Urioste
Independent Director
Willem P. Elfrink
Independent Director
Michael R. Jaff
Independent Director
Kenneth Nelson
Independent Director
Marga Ortigas-Wedekind
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US42238H1086
  • Market cap
    $64.00m
  • Employees
    15
  • Shares in issue
    26.67m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.